Literature DB >> 19205904

Ex-drinking may be a surrogate for unmeasured risk factors for upper gastrointestinal bleeding: reappraisal and an additional survey of subjects from a case-control study in Japan.

Hikaru Watanabe1, Yukari Kamijima, Tsugumichi Sato, David W Kaufman, Kiyoshi Kubota.   

Abstract

In our recent case-control study on the association between non-steroidal anti-inflammatory drugs (NSAIDs) and upper gastrointestinal bleeding (UGIB), the risk of UGIB was higher in non-drinkers than in heavy-drinkers. To explore this unexpected finding, we re-analyzed the data to test whether non-drinking represented risk factors for UGIB and also conducted an additional survey to find any disagreement with the original study that might suggest information bias. In the re-analysis, we estimated odds ratios (ORs) of UGIB by classifying 183 non-drinkers in the original study into 39 ex- and 144 never-drinkers. We also measured the prevalence of potential risk factors of UGIB in controls. In the new survey, we sent a self-administered questionnaire on previous alcohol consumption. In the re-analysis, the OR for ex-drinking (5.4) was higher and the OR for never-drinking (2.6) was lower than the OR for non- (ex- plus never-) drinking (3.2) in the original study. Ex-drinkers had higher prevalence of H. pylori infection, history of previous ulcer and use of GI drugs than other types of drinkers. The answers on their previous alcohol consumption were consistent between the original and new surveys both in cases (kappa = 0.74) and controls (kappa = 0.73). Ex-drinking may represent unmeasured risk factors for UGIB such as undiagnosed ulcer. In an observational study of UGIB, ex-drinking may be distinguished from never-drinking as a potential surrogate for UGIB risk. When prescribing an NSAID to an ex-drinker in clinical practice, one may make sure to explore whether an ex-drinker has a history of ulcer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205904     DOI: 10.1007/s10654-009-9319-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  18 in total

1.  Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding.

Authors:  N R Dunn; G L Pearce; S A Shakir
Journal:  BMJ       Date:  2000-05-20

2.  Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

Authors:  F J de Abajo; L A Rodríguez; D Montero
Journal:  BMJ       Date:  1999-10-23

3.  Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study.

Authors:  I B Andersen; T Jørgensen; O Bonnevie; M Grønbaek; T I Sørensen
Journal:  Epidemiology       Date:  2000-07       Impact factor: 4.822

4.  The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption.

Authors:  D W Kaufman; J P Kelly; B E Wiholm; A Laszlo; J E Sheehan; R S Koff; S Shapiro
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

5.  Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial.

Authors:  D C Bauer; D Black; K Ensrud; D Thompson; M Hochberg; M Nevitt; T Musliner; D Freedholm
Journal:  Arch Intern Med       Date:  2000-02-28

6.  Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study.

Authors:  G L Nielsen; H T Sørensen; L Mellemkjoer; W J Blot; J K McLaughlin; U Tage-Jensen; J H Olsen
Journal:  Am J Med       Date:  2001-11       Impact factor: 4.965

7.  Spironolactone and risk of upper gastrointestinal events: population based case-control study.

Authors:  Katia Verhamme; Georgio Mosis; Jeanne Dieleman; Bruno Stricker; Miriam Sturkenboom
Journal:  BMJ       Date:  2006-07-13

8.  Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study.

Authors:  Xavier Vidal; Luisa Ibáñez; Lourdes Vendrell; Ana Conforti; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study.

Authors:  Sinem E Gulmez; Annmarie T Lassen; Claus Aalykke; Michael Dall; Alin Andries; Birthe S Andersen; Jane M Hansen; Morten Andersen; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2008-04-21       Impact factor: 4.335

10.  Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.

Authors:  Susanne Oksbjerg Dalton; Christoffer Johansen; Lene Mellemkjaer; Bente Nørgård; Henrik Toft Sørensen; Jørgen H Olsen
Journal:  Arch Intern Med       Date:  2003-01-13
View more
  3 in total

1.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

2.  New studies, technology, and the progress of epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-12       Impact factor: 8.082

3.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.